Showing results (1281-1290 of 2,818) with videos related to

Sort By:
Pageof 282
Diabetes Technology & Therapeutics|January 22, 2015
Trigger matters: an ergonomy analysis of insulin pensWojciech Fendler, Danuta Roman-Liu, Tomasz Tokarski, et al.
Diabetes Technology & Therapeutics|July 25, 2012
Prevalence of diabetes in Asian Indians based on glycated hemoglobin and fasting and 2-H post-load (75-g) plasma glucose (CURES-120)Adamsha Nazir, Rozario Papita, Viknesh Prabu Anbalagan, et al.
Diabetes Technology & Therapeutics|July 18, 2022
Association Between Time in Range and Postprandial Glucose Contribution Rate in Non-Insulin-Treated Type 2 Diabetes Patients: Inverse Correlation of Time in Range with Postprandial Glucose Contribution RateFumi Uemura, Yosuke Okada, Keiichi Torimoto, et al.
Diabetes Technology & Therapeutics|March 21, 2023
Reduced Acute Diabetes Events After FreeStyle Libre System Initiation in People 65 Years or Older with Type 2 Diabetes on Intensive Insulin Therapy in FranceBruno Guerci, Fleur Levrat-Guillen, Eric Vicaut, et al.
Diabetes Technology & Therapeutics|August 12, 2016
From Two to One Per Day Calibration of Dexcom G4 Platinum by a Time-Varying Day-Specific Bayesian PriorGiada Acciaroli, Martina Vettoretti, Andrea Facchinetti, et al.
Diabetes Technology & Therapeutics|July 9, 2015
Screening for Type 2 Diabetes and Dysglycemia in Saudi Arabia: Development and Validation of Risk ScoresZiad A Memish, Jennifer L Chang, Mohammad Y Saeedi, et al.
Diabetes Technology & Therapeutics|July 15, 2015
The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring SystemTimothy Bailey, Bruce W Bode, Mark P Christiansen, et al.
Diabetes Technology & Therapeutics|July 15, 2015
Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with Type 2 Diabetes Uncontrolled by Oral Hypoglycemic Agents in China--Study Design and Baseline CharacteristicsLinong Ji, Puhong Zhang, Jianping Weng, et al.
Diabetes Technology & Therapeutics|August 10, 2022
Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the Diabetes-Patienten-Verlaufsdokumentation Initiative and Type 1 Diabetes Exchange Quality Improvement CollaborativeDaniel J DeSalvo, Stefanie Lanzinger, Nudrat Noor, et al.
Diabetes Technology & Therapeutics|August 10, 2022
Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes Mellitus Patients: Results from the Spanish National RegistryJesus Moreno-Fernandez, Ana Chico, María Asunción Martínez-Brocca, et al.
Pageof 282